当前位置:首页 - 行情中心 - 华北制药(600812) - 财务分析 - 资产负债表

华北制药

(600812)

  

流通市值:80.12亿  总市值:80.12亿
流通股本:17.16亿   总股本:17.16亿

资产负债表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
流动资产:
  货币资金1,509,260,549.941,179,654,647.041,384,871,890.281,541,414,202.12
  应收票据及应收账款2,437,014,290.532,549,737,177.862,604,085,233.42,411,368,822.43
        应收账款2,437,014,290.532,549,737,177.862,604,085,233.42,411,368,822.43
  应收款项融资221,447,146.61265,583,560.89259,054,539.81183,670,124.47
  预付款项98,779,600.88114,979,068.98107,247,114.9393,989,453.56
  其他应收款合计1,281,606,055.581,272,819,718.341,395,477,329.931,382,129,629.94
  其中:应收利息--175,000175,000
  存货2,543,445,629.972,472,074,763.152,413,363,684.092,410,852,410.36
  其他流动资产93,108,100.17123,381,451.76101,250,614.78107,871,454.5
  流动资产合计8,184,661,373.687,978,230,388.028,265,350,407.228,131,296,097.38
非流动资产:
  长期股权投资1,291,040,320.981,277,486,915.131,261,742,427.131,247,085,553.17
  其他权益工具投资5,035,0005,035,0005,035,0005,035,000
  固定资产6,042,132,954.46,144,216,650.076,223,254,1286,362,233,837.34
  在建工程304,961,442.11321,900,162.62269,048,271.09259,600,989.02
  使用权资产162,551,602.19169,128,876.77248,024,031.25257,803,948.97
  无形资产3,055,419,574.93,032,218,488.62,987,910,610.223,024,497,212.09
  开发支出2,138,172,632.882,073,635,144.332,073,185,197.611,986,986,026.04
  长期待摊费用73,238,207.6275,119,266.0967,571,620.8468,214,510.22
  递延所得税资产51,423,303.8651,652,922.9850,889,164.7449,150,212.73
  非流动资产合计13,123,975,038.9413,150,393,426.5913,186,660,450.8813,260,607,289.58
  资产总计21,308,636,412.6221,128,623,814.6121,452,010,858.121,391,903,386.96
流动负债:
  短期借款5,245,691,915.285,736,841,515.286,366,431,515.286,242,124,372.07
  应付票据及应付账款2,560,431,003.112,527,083,117.772,429,543,702.572,451,020,041.53
  其中:应付票据503,023,023497,002,217.98448,512,698.42476,610,979.31
        应付账款2,057,407,980.112,030,080,899.791,981,031,004.151,974,409,062.22
  合同负债151,804,535.46133,067,022.13164,984,118.37161,481,735.16
  应付职工薪酬150,679,035.54189,440,038.79189,619,334.02183,604,195.52
  应交税费46,159,111.1844,134,044.0563,324,823.160,266,659.35
  其他应付款合计297,699,285.38307,813,669.42308,268,168.92310,697,076.33
  其中:应付利息2,058,544.78641,854.492,170,999.66771,055.86
        应付股利9,208,029.96385,687.5385,687.5385,687.5
  一年内到期的非流动负债1,202,085,588.251,548,754,074.181,894,024,627.912,971,999,114.5
  其他流动负债15,750,153.5712,697,163.5720,470,238.7918,071,190.23
  流动负债合计9,670,300,627.7710,499,830,645.1911,436,666,528.9612,399,264,384.69
非流动负债:
  长期借款4,064,607,0003,048,858,0002,351,818,0001,376,674,659.72
  应付债券500,000,000500,000,000500,000,000500,000,000
  租赁负债101,342,413.18104,458,874.49124,529,982.74124,434,082.95
  长期应付款16,180,00016,180,00016,180,00016,180,000
  递延收益97,105,296.5990,783,187.1688,373,585.8289,802,253.57
  递延所得税负债551,027.44551,027.44551,027.44551,027.44
  非流动负债合计4,779,785,737.213,760,831,089.093,081,452,5962,107,642,023.68
  负债合计14,450,086,364.9814,260,661,734.2814,518,119,124.9614,506,906,408.37
所有者权益(或股东权益):
  实收资本(或股本)1,715,730,3701,715,730,3701,715,730,3701,715,730,370
  资本公积3,869,792,395.773,869,826,456.163,869,810,132.553,869,792,329.16
  其他综合收益-10,008,118.94-9,221,598.65-7,974,360.77-6,312,061.39
  专项储备3,480,300.273,442,189.961,969,228.75806,861.4
  盈余公积339,420,156.84339,420,156.84339,420,156.84339,420,156.84
  未分配利润-399,765,254.52-400,811,036.21-369,133,555.76-404,606,383.25
  归属于母公司股东权益合计5,518,649,849.425,518,386,538.15,549,821,971.615,514,831,272.76
  少数股东权益1,339,900,198.221,349,575,542.231,384,069,761.531,370,165,705.83
  股东权益合计6,858,550,047.646,867,962,080.336,933,891,733.146,884,996,978.59
  负债和股东权益合计21,308,636,412.6221,128,623,814.6121,452,010,858.121,391,903,386.96
公告日期2026-10-282026-08-222026-04-252026-04-18
审计意见(境内)标准无保留意见
TOP↑